TRIM33 and dermatomyositis: A retrospective analysis by Harada et al. analyzed 14 patients with anti-TIF1γ positivity out of a pool of 85 patients with DM over a prolonged 18-year course and identified dermatologic manifestations such as erythema, V neck sign, heliotrope rash, and nail fold telangiectasias more frequently present, whereas no patients developed features of ILD on HRCT (77).